What Can Affect hCG Levels in Pregnancy?

Dozens of factors can push hCG levels higher or lower than expected during pregnancy, ranging from how many embryos are present to a mother’s body weight, smoking status, kidney function, and even the specific lab test used to measure the hormone. In a typical singleton pregnancy, hCG becomes detectable in the blood about eight to ten days after ovulation, doubles roughly every one and a half to two days in early weeks, peaks somewhere around eight to ten weeks, and then gradually declines. Understanding what nudges those numbers off the expected curve matters because clinicians use hCG trends to assess whether a pregnancy is progressing normally, to screen for chromosomal conditions, and to flag complications like ectopic implantation.

The Normal Trajectory and Why It Varies

After implantation, hCG rises steeply. Levels sit around 50 to 100 IU/L near the time of a missed period, then climb to a peak of roughly 50,000 to 100,000 IU/L by eight to ten weeks of gestation. After that peak, concentrations fall back to about 10,000 to 20,000 IU/L by the midpoint of pregnancy and hold there until delivery.¹ The familiar “doubling time” that gets quoted in early pregnancy is not fixed. It changes with both gestational age and the current hCG concentration, so what counts as a normal rise at five weeks is different from what is normal at seven weeks.² That shifting baseline is the first reason two perfectly healthy pregnancies can show quite different numbers on the same day.

Carrying More Than One Baby

Twin and higher-order pregnancies produce markedly higher hCG. In one study comparing twins to singletons, peak hCG around nine to eleven weeks averaged about 171,000 U/L in twin pregnancies versus roughly 65,500 U/L in singletons, and the elevated concentrations lasted far longer. Levels above 75,000 U/L persisted for up to six weeks in twins compared with less than one week in singletons.³ Interestingly, although the absolute levels are much higher in multiples, the rate at which hCG doubles in the earliest weeks appears similar for single and multiple pregnancies.⁴ That means a very high early value can hint at twins, but a normal doubling time does not rule them out.

Ectopic Pregnancy

When an embryo implants outside the uterus, hCG still rises, but much more sluggishly than in a normal intrauterine pregnancy. In one early study of asymptomatic women, nearly all ectopic pregnancies showed a doubling time exceeding 2.2 days, and the daily hCG increase stayed below 190 IU/L per day, while most intrauterine pregnancies exceeded that threshold.⁵ Later research refined the picture by combining the hCG trend with ultrasound findings. Patients whose hCG rose by less than 66% over 48 hours and who had an empty uterus on ultrasound faced the highest risk, while those whose hCG fell by more than half were at low risk regardless of what the ultrasound showed.⁶ Clinicians rarely diagnose ectopic pregnancy from a single hCG number alone; the trend over two or more blood draws, combined with imaging, is what guides them.

Early Pregnancy Loss

A substantial share of pregnancies end so early that they are never detected by a standard home test. In a landmark study that tracked daily urine hCG in women trying to conceive, about 22% of confirmed pregnancies ended before they were clinically recognized.⁷ In these very early losses, hCG rises briefly and then falls, sometimes producing a faintly positive home test followed by what appears to be a normal or slightly late period. For pregnancies that are clinically established before miscarriage occurs, hCG levels typically plateau or decline rather than showing the expected doubling pattern. A single low reading is not diagnostic on its own, but a clearly falling trend usually confirms that the pregnancy is no longer viable.

Molar Pregnancy and Gestational Trophoblastic Disease

At the opposite extreme from a failing pregnancy, a molar pregnancy can push hCG into the stratosphere. In a complete hydatidiform mole, the placental tissue grows abnormally and churns out far more hCG than a normal pregnancy at the same gestational age. One study found that hCG levels in complete moles were dramatically higher week by week compared with non-molar miscarriages: by ten to eleven weeks, the median in the molar group was over 126,000 mIU/mL versus roughly 30,000 mIU/mL in the non-molar group.⁸ Because molar pregnancies carry a small risk of becoming cancerous, unusually high hCG for gestational age is a red flag that prompts further investigation with ultrasound and, if confirmed, close monitoring after the mole is removed.

Maternal Body Weight

Body weight has a measurable effect on circulating hCG, though the mechanism is not entirely settled. Women who are overweight tend to have lower hCG concentrations across early pregnancy compared with women at a normal weight.⁹ In IVF pregnancies, where hCG can be measured very precisely and early, a large difference in weight was associated with a substantial drop in hCG: a 100-pound difference corresponded to about a 35% lower initial hCG reading.¹⁰ The likeliest explanation is dilution: a larger blood volume spreads the same amount of hormone across more fluid. This matters practically because a heavier person might see a lower number on a blood test and worry unnecessarily, or a prenatal screening result might need weight-based correction to be accurate.

Smoking

Cigarette smoking consistently lowers hCG. One study found that smokers had hCG levels roughly 21% lower than nonsmokers, with a steady dose-response relationship: heavier smoking meant lower levels.¹¹ Other work has confirmed this in the context of prenatal screening, where smoking reduced first-trimester hCG to about 80% of the expected level and second-trimester hCG to about 84%.¹² Because prenatal screening programs use hCG as one of their inputs, most labs ask whether a patient smokes and apply a correction factor. Without that adjustment, a smoker’s lower hCG could shift a screening result and either mask or falsely elevate the estimated risk for chromosomal conditions.¹³

Fertility Treatments and IVF

If you have undergone IVF or another fertility treatment, there is an extra wrinkle: the hCG trigger shot given to mature eggs before retrieval stays in the bloodstream for days afterward. Serum hCG from the injection remains detectable for up to 14 days, with less than 10% of the original dose still present by day 10. The injected hCG has a half-life of about 2.3 days.¹⁴ That means a pregnancy blood test taken too soon after the trigger can pick up leftover medication rather than true pregnancy-related hCG, giving a falsely encouraging or confusing number. To avoid this, fertility clinics typically wait about 10 to 14 days post-trigger before drawing blood for a definitive pregnancy test. Some newer protocols use much smaller, repeated micro-doses of hCG for luteal phase support, which complicates the picture further because there is a continuous low-level drip of exogenous hormone overlapping with whatever the embryo is producing.¹⁵

Kidney Function

The kidneys play a larger role in hCG clearance than most people realize. About 30% of circulating hCG is filtered out by the kidneys, and the kidneys also metabolize an additional fraction.¹⁶ When kidney function is impaired, less hCG gets cleared, so blood levels run higher than they otherwise would. Even subtle differences in kidney filtration can nudge the numbers. One study found that women with unusually elevated free beta-hCG during first-trimester screening had, on average, slightly reduced kidney filtration rates compared with women whose levels were normal.¹⁷ For most pregnant women this is a minor factor, but for anyone with known kidney disease, it can explain an otherwise puzzling elevation and potentially distort prenatal screening results.

Placental Health and Later Pregnancy Complications

Because hCG is produced by the placenta, unusually high levels in the second trimester have been studied as a possible early warning sign for placental problems. A systematic review and meta-analysis found that elevated hCG (above roughly twice the expected median for gestational age) was associated with about double the risk of preeclampsia and a modestly increased risk of preterm delivery, though the overall confidence in that evidence was rated low.¹⁸ Another meta-analysis reached a similar conclusion, linking high second-trimester hCG to growth restriction, pregnancy-induced hypertension, preterm delivery, and miscarriage, and suggesting the underlying connection is that abnormal hCG reflects abnormal placental function.¹⁹ A large population-based study found that high hCG carried a 1.5 to 2.7 times increased risk of preeclampsia, depending on the threshold used.²⁰ The association is real, but it is not strong enough on its own to predict these outcomes for any individual patient. Many women with elevated hCG have entirely uneventful pregnancies.

How the Lab Test Itself Can Shift Results

Not all hCG tests measure the same thing, and the variation between commercial assays is surprisingly large. hCG exists in the body in several structural forms: the intact molecule, a free beta subunit, a hyperglycosylated version that predominates very early in pregnancy, nicked fragments, and a core fragment found mainly in urine. Different test platforms detect these forms to very different degrees. One comparison of nine commonly used serum assays found wide variation in how well each detected structural variants. For instance, the reported concentration for hyperglycosylated hCG ranged from 468 to 1,544 IU/L across the nine assays testing the same sample.²¹ A separate evaluation found that while one assay platform detected eight out of nine hCG variant forms, several others detected only two or three.²²

The practical takeaway is that comparing hCG numbers from two different labs or two different test platforms can be misleading. A reading of 5,000 at one lab and 4,200 at another might reflect assay differences rather than a genuine change in the pregnancy. This is one reason clinicians prefer serial draws from the same laboratory, using the same assay, when tracking hCG trends.

False Positives and the Hook Effect

Occasionally, lab results can be outright wrong. Certain antibodies in a patient’s blood, called heterophile antibodies or human anti-mouse antibodies, can interfere with the immunoassay chemistry and produce a falsely elevated hCG reading. In one documented case, a 45-year-old woman was misdiagnosed as pregnant because anti-mouse antibodies in her serum tricked the assay.²³ When a false positive is suspected, labs can add a blocking agent that neutralizes the interfering antibodies and rerun the test, which typically brings the result back to normal.²⁴

In the opposite direction, extremely high hCG can paradoxically cause a urine pregnancy test to read negative, a phenomenon known as the hook effect. When the hormone concentration is so high that it saturates the test strip’s antibodies, the assay cannot form the sandwich complex it needs to generate a positive line. This has led to situations where pregnant women with conditions like molar pregnancy or very advanced gestations receive a falsely negative urine result.²⁵ Diluting the urine sample and retesting usually resolves the issue, because it brings the hCG concentration back into the assay’s working range.

How hCG Fits Into Prenatal Screening

Beyond diagnosing pregnancy itself, hCG is one of several blood markers used in prenatal screening for chromosomal conditions. In first-trimester combined screening, free beta-hCG is measured alongside another protein and combined with an ultrasound measurement of fluid at the back of the fetal neck. In second-trimester screening, total hCG or free beta-hCG joins alpha-fetoprotein and other markers.²⁶ The hCG result is typically reported as a multiple of the median (a ratio comparing your level to the middle value for your gestational age), and this ratio is then adjusted for factors like weight and smoking status.²⁷ This is why the factors discussed throughout this article are not just academic curiosities; they directly feed into clinical decisions. An uncorrected weight or smoking effect could shift a screening result from low-risk to high-risk or vice versa.

hCG Changes as the Placenta Matures

The type of hCG your body produces shifts as pregnancy progresses. Very early on, the dominant form is a hyperglycosylated version of the molecule, which is thought to play a key role in the invading trophoblast cells that burrow into the uterine wall to establish the placenta. This form appears within days of implantation and is then rapidly replaced by the standard isoform that predominates for the rest of pregnancy.²⁸ This transition is not just a biochemical footnote. Because different lab assays detect the hyperglycosylated form to different degrees, a test that is sensitive to it might give a higher reading in very early pregnancy than one that is not, even when the total amount of hCG-related molecules is identical. The shifting isoform profile is one more reason why serial testing at the same lab is the most reliable way to track hCG trends.

When hCG Shows Up Without a Pregnancy

Elevated hCG outside of pregnancy is uncommon but carries important implications. Certain cancers, including gestational trophoblastic neoplasia, some ovarian germ cell tumors, and occasionally cancers of the bladder, lung, or gastrointestinal tract, can produce hCG. One case report documented a 31-year-old woman initially thought to be pregnant whose elevated hCG turned out to be caused by gallbladder cancer.²⁹ Up to about 20% of colorectal cancers can secrete beta-hCG, usually at low levels.³⁰ These are rare scenarios, but they underline why a positive hCG result in someone who cannot be pregnant always warrants follow-up.

There is also a benign explanation that trips up clinicians more often than it should. A small percentage of perimenopausal and postmenopausal women have mildly elevated hCG, typically below 14 IU/L, produced by the pituitary gland rather than by pregnancy tissue. Occasionally the pituitary output can climb higher. One case involved a 53-year-old menopausal woman with an hCG above 40 IU/L whose levels normalized after she was given estrogen-progesterone replacement, confirming the pituitary as the source. Without that test, the elevation could have triggered unnecessary workup for malignancy or a suspected pregnancy.

Nausea and the hCG Connection

The timing of morning sickness maps suspiciously well onto the hCG curve. Nausea and vomiting affect roughly 70 to 80% of pregnant women, and symptoms typically peak right around the same eight-to-ten-week window when hCG hits its highest levels. While the exact cause of pregnancy nausea remains debated, and multiple hormonal and neurological factors are involved, higher hCG concentrations have long been one of the leading suspects. Women carrying twins, who have higher hCG, tend to report more severe nausea, and women with molar pregnancies, where hCG can be extremely elevated, often experience intense vomiting. None of this means that a woman with mild nausea has low hCG or that severe nausea guarantees high levels. Symptom severity is influenced by individual sensitivity, genetics, and other hormones. But the correlation between the hCG peak and the worst weeks of nausea is one of the most consistent patterns in early pregnancy.